The pharmaceutical market for obesity therapies

被引：32

作者：

Wong, Donny ^{[1
]}

Sullivan, Kate ^{[1
]}

Heap, Gideon ^{[1
]}

机构：

[1] Decis Resources, London EC4N 1TX, England

来源：

NATURE REVIEWS DRUG DISCOVERY | 2012年 / 11卷 / 09期

关键词：

D O I：

10.1038/nrd3830

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

In the wake of the recent approvals of the first new obesity therapies in more than a decade, Wong and colleagues analyse their market prospects as well as the late-stage pipeline.

引用

页码：669 / 670

页数：2

共 2 条

[1] The medical care costs of obesity: An instrumental variables approach [J].

Cawley, John ;

Meyerhoefer, Chad .

JOURNAL OF HEALTH ECONOMICS, 2012, 31 (01) :219-230

[2] Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies [J].

Whitlock, Gary ;

Lewington, Sarah ;

Sherliker, Paul ;

Clarke, Robert ;

Emberson, Jonathan ;

Halsey, Jim ;

Qizilbash, Nawab ;

Collins, Rory ;

Peto, Richard ;

Lewington, S. ;

MacMahon, S. ;

Peto, R. ;

Aromaa, A. ;

Baigent, C. ;

Carstensen, J. ;

Chen, Z. ;

Clarke, R. ;

Collins, R. ;

Duffy, S. ;

Kromhout, D. ;

Neaton, J. ;

Qizilbash, N. ;

Rodgers, A. ;

Tominaga, S. ;

Toernberg, S. ;

Tunstall-Pedoe, H. ;

Whitlock, G. ;

Chambless, L. ;

De Backer, G. ;

De Bacquer, D. ;

Kornitzer, M. ;

Whincup, P. ;

Wannamethee, S. G. ;

Morris, R. ;

Wald, N. ;

Morris, J. ;

Law, M. ;

Knuiman, M. ;

Bartholomew, H. ;

Smith, G. Davey ;

Sweetnam, P. ;

Elwood, P. ;

Yarnell, J. ;

Kronmal, R. ;

Kromhout, D. ;

Sutherland, S. ;

Keil, J. ;

Jensen, G. ;

Schnohr, P. ;

Hames, C. .

LANCET, 2009, 373 (9669) :1083-1096

← 1 →